The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Hemostatic and Tissue Sealing Agents Market Outlook 2024

Global Hemostatic and Tissue Sealing Agents Market Outlook 2024

Publishing Date : Jan, 2022

License Type :
 

Report Code : 1665993

No of Pages : 128

Synopsis
Hemostasis is defined as "the blocking of bleeding or bleeding through blood vessels or other parts of the body".Hemostatic agents and tissue adhesives are used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.The industry is driven by a growing base of older people and an increase in the prevalence of chronic diseases.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.Chronic diseases eventually lead to surgery for patients, which in turn promotes the development of the hemostasis and tissue sealant industries.
Global Hemostatic and Tissue Sealing Agents key players include J&J, Baxter, C R Bard, etc. Global top three manufacturers hold a share over 45%.
North America is the largest market, with a share about 60%, followed by China, and Europe, both have a share about 30 percent.
In terms of product, Hemostatic is the largest segment, with a share about 75%. And in terms of application, the largest application is General Surgery, followed by Minimally Invasive Surgery, etc.

The global Hemostatic and Tissue Sealing Agents market was valued at US$ 2720.2 million in 2020 and is expected to reach US$ 3345.5 million by the end of 2027, growing at a CAGR of 3.0% during 2021-2027.
This report focuses on Hemostatic and Tissue Sealing Agents volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Hemostatic and Tissue Sealing Agents market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Hemostatic and Tissue Sealing Agents Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Hemostatic
Sealant Gum

Segment by Application
Minimally Invasive Surgery
General Surgery
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
J&J
Baxter
C R Bard
B Braun
Integra Life Sciences
Advance Medical Solution
CSL Behring
CryoLife
Zimmer Biomet
Pfizer
Medtronic
Smith & Nephew
Cohera Medical
Shanghai Haohai Biological Technology Co. Ltd.
Shandong Saikesaisi Biotechnology Co., Ltd
Chang ShaHai Run biological technology Co, LTD
Index
1 Hemostatic and Tissue Sealing Agents Market Overview
1.1 Product Overview and Scope of Hemostatic and Tissue Sealing Agents
1.2 Hemostatic and Tissue Sealing Agents Segment by Type
1.2.1 Global Hemostatic and Tissue Sealing Agents Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Hemostatic
1.2.3 Sealant Gum
1.3 Hemostatic and Tissue Sealing Agents Segment by Application
1.3.1 Global Hemostatic and Tissue Sealing Agents Sales Comparison by Application: (2021-2027)
1.3.2 Minimally Invasive Surgery
1.3.3 General Surgery
1.3.4 Other
1.4 Global Hemostatic and Tissue Sealing Agents Market Size Estimates and Forecasts
1.4.1 Global Hemostatic and Tissue Sealing Agents Revenue 2016-2027
1.4.2 Global Hemostatic and Tissue Sealing Agents Sales 2016-2027
1.4.3 Hemostatic and Tissue Sealing Agents Market Size by Region: 2016 Versus 2021 Versus 2027

2 Hemostatic and Tissue Sealing Agents Market Competition by Manufacturers
2.1 Global Hemostatic and Tissue Sealing Agents Sales Market Share by Manufacturers (2016-2021)
2.2 Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Hemostatic and Tissue Sealing Agents Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Hemostatic and Tissue Sealing Agents Manufacturing Sites, Area Served, Product Type
2.5 Hemostatic and Tissue Sealing Agents Market Competitive Situation and Trends
2.5.1 Hemostatic and Tissue Sealing Agents Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Hemostatic and Tissue Sealing Agents Players Market Share by Revenue
2.5.3 Global Hemostatic and Tissue Sealing Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Hemostatic and Tissue Sealing Agents Retrospective Market Scenario by Region
3.1 Global Hemostatic and Tissue Sealing Agents Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Hemostatic and Tissue Sealing Agents Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Hemostatic and Tissue Sealing Agents Market Facts & Figures by Country
3.3.1 North America Hemostatic and Tissue Sealing Agents Sales by Country
3.3.2 North America Hemostatic and Tissue Sealing Agents Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Hemostatic and Tissue Sealing Agents Market Facts & Figures by Country
3.4.1 Europe Hemostatic and Tissue Sealing Agents Sales by Country
3.4.2 Europe Hemostatic and Tissue Sealing Agents Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Hemostatic and Tissue Sealing Agents Market Facts & Figures by Region
3.5.1 Asia Pacific Hemostatic and Tissue Sealing Agents Sales by Region
3.5.2 Asia Pacific Hemostatic and Tissue Sealing Agents Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Hemostatic and Tissue Sealing Agents Market Facts & Figures by Country
3.6.1 Latin America Hemostatic and Tissue Sealing Agents Sales by Country
3.6.2 Latin America Hemostatic and Tissue Sealing Agents Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Hemostatic and Tissue Sealing Agents Market Facts & Figures by Country
3.7.1 Middle East and Africa Hemostatic and Tissue Sealing Agents Sales by Country
3.7.2 Middle East and Africa Hemostatic and Tissue Sealing Agents Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Hemostatic and Tissue Sealing Agents Historic Market Analysis by Type
4.1 Global Hemostatic and Tissue Sealing Agents Sales Market Share by Type (2016-2021)
4.2 Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Type (2016-2021)
4.3 Global Hemostatic and Tissue Sealing Agents Price by Type (2016-2021)

5 Global Hemostatic and Tissue Sealing Agents Historic Market Analysis by Application
5.1 Global Hemostatic and Tissue Sealing Agents Sales Market Share by Application (2016-2021)
5.2 Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Application (2016-2021)
5.3 Global Hemostatic and Tissue Sealing Agents Price by Application (2016-2021)

6 Key Companies Profiled
6.1 J&J
6.1.1 J&J Corporation Information
6.1.2 J&J Description and Business Overview
6.1.3 J&J Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2016-2021)
6.1.4 J&J Hemostatic and Tissue Sealing Agents Product Portfolio
6.1.5 J&J Recent Developments/Updates
6.2 Baxter
6.2.1 Baxter Corporation Information
6.2.2 Baxter Description and Business Overview
6.2.3 Baxter Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Baxter Hemostatic and Tissue Sealing Agents Product Portfolio
6.2.5 Baxter Recent Developments/Updates
6.3 C R Bard
6.3.1 C R Bard Corporation Information
6.3.2 C R Bard Description and Business Overview
6.3.3 C R Bard Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2016-2021)
6.3.4 C R Bard Hemostatic and Tissue Sealing Agents Product Portfolio
6.3.5 C R Bard Recent Developments/Updates
6.4 B Braun
6.4.1 B Braun Corporation Information
6.4.2 B Braun Description and Business Overview
6.4.3 B Braun Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2016-2021)
6.4.4 B Braun Hemostatic and Tissue Sealing Agents Product Portfolio
6.4.5 B Braun Recent Developments/Updates
6.5 Integra Life Sciences
6.5.1 Integra Life Sciences Corporation Information
6.5.2 Integra Life Sciences Description and Business Overview
6.5.3 Integra Life Sciences Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Integra Life Sciences Hemostatic and Tissue Sealing Agents Product Portfolio
6.5.5 Integra Life Sciences Recent Developments/Updates
6.6 Advance Medical Solution
6.6.1 Advance Medical Solution Corporation Information
6.6.2 Advance Medical Solution Description and Business Overview
6.6.3 Advance Medical Solution Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Advance Medical Solution Hemostatic and Tissue Sealing Agents Product Portfolio
6.6.5 Advance Medical Solution Recent Developments/Updates
6.7 CSL Behring
6.6.1 CSL Behring Corporation Information
6.6.2 CSL Behring Description and Business Overview
6.6.3 CSL Behring Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2016-2021)
6.4.4 CSL Behring Hemostatic and Tissue Sealing Agents Product Portfolio
6.7.5 CSL Behring Recent Developments/Updates
6.8 CryoLife
6.8.1 CryoLife Corporation Information
6.8.2 CryoLife Description and Business Overview
6.8.3 CryoLife Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2016-2021)
6.8.4 CryoLife Hemostatic and Tissue Sealing Agents Product Portfolio
6.8.5 CryoLife Recent Developments/Updates
6.9 Zimmer Biomet
6.9.1 Zimmer Biomet Corporation Information
6.9.2 Zimmer Biomet Description and Business Overview
6.9.3 Zimmer Biomet Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Zimmer Biomet Hemostatic and Tissue Sealing Agents Product Portfolio
6.9.5 Zimmer Biomet Recent Developments/Updates
6.10 Pfizer
6.10.1 Pfizer Corporation Information
6.10.2 Pfizer Description and Business Overview
6.10.3 Pfizer Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Pfizer Hemostatic and Tissue Sealing Agents Product Portfolio
6.10.5 Pfizer Recent Developments/Updates
6.11 Medtronic
6.11.1 Medtronic Corporation Information
6.11.2 Medtronic Hemostatic and Tissue Sealing Agents Description and Business Overview
6.11.3 Medtronic Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Medtronic Hemostatic and Tissue Sealing Agents Product Portfolio
6.11.5 Medtronic Recent Developments/Updates
6.12 Smith & Nephew
6.12.1 Smith & Nephew Corporation Information
6.12.2 Smith & Nephew Hemostatic and Tissue Sealing Agents Description and Business Overview
6.12.3 Smith & Nephew Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Smith & Nephew Hemostatic and Tissue Sealing Agents Product Portfolio
6.12.5 Smith & Nephew Recent Developments/Updates
6.13 Cohera Medical
6.13.1 Cohera Medical Corporation Information
6.13.2 Cohera Medical Hemostatic and Tissue Sealing Agents Description and Business Overview
6.13.3 Cohera Medical Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Cohera Medical Hemostatic and Tissue Sealing Agents Product Portfolio
6.13.5 Cohera Medical Recent Developments/Updates
6.14 Shanghai Haohai Biological Technology Co. Ltd.
6.14.1 Shanghai Haohai Biological Technology Co. Ltd. Corporation Information
6.14.2 Shanghai Haohai Biological Technology Co. Ltd. Hemostatic and Tissue Sealing Agents Description and Business Overview
6.14.3 Shanghai Haohai Biological Technology Co. Ltd. Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Shanghai Haohai Biological Technology Co. Ltd. Hemostatic and Tissue Sealing Agents Product Portfolio
6.14.5 Shanghai Haohai Biological Technology Co. Ltd. Recent Developments/Updates
6.15 Shandong Saikesaisi Biotechnology Co., Ltd
6.15.1 Shandong Saikesaisi Biotechnology Co., Ltd Corporation Information
6.15.2 Shandong Saikesaisi Biotechnology Co., Ltd Hemostatic and Tissue Sealing Agents Description and Business Overview
6.15.3 Shandong Saikesaisi Biotechnology Co., Ltd Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Shandong Saikesaisi Biotechnology Co., Ltd Hemostatic and Tissue Sealing Agents Product Portfolio
6.15.5 Shandong Saikesaisi Biotechnology Co., Ltd Recent Developments/Updates
6.16 Chang ShaHai Run biological technology Co, LTD
6.16.1 Chang ShaHai Run biological technology Co, LTD Corporation Information
6.16.2 Chang ShaHai Run biological technology Co, LTD Hemostatic and Tissue Sealing Agents Description and Business Overview
6.16.3 Chang ShaHai Run biological technology Co, LTD Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Chang ShaHai Run biological technology Co, LTD Hemostatic and Tissue Sealing Agents Product Portfolio
6.16.5 Chang ShaHai Run biological technology Co, LTD Recent Developments/Updates

7 Hemostatic and Tissue Sealing Agents Manufacturing Cost Analysis
7.1 Hemostatic and Tissue Sealing Agents Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Hemostatic and Tissue Sealing Agents
7.4 Hemostatic and Tissue Sealing Agents Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Hemostatic and Tissue Sealing Agents Distributors List
8.3 Hemostatic and Tissue Sealing Agents Customers

9 Hemostatic and Tissue Sealing Agents Market Dynamics
9.1 Hemostatic and Tissue Sealing Agents Industry Trends
9.2 Hemostatic and Tissue Sealing Agents Growth Drivers
9.3 Hemostatic and Tissue Sealing Agents Market Challenges
9.4 Hemostatic and Tissue Sealing Agents Market Restraints

10 Global Market Forecast
10.1 Hemostatic and Tissue Sealing Agents Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Hemostatic and Tissue Sealing Agents by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Hemostatic and Tissue Sealing Agents by Type (2022-2027)
10.2 Hemostatic and Tissue Sealing Agents Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Hemostatic and Tissue Sealing Agents by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Hemostatic and Tissue Sealing Agents by Application (2022-2027)
10.3 Hemostatic and Tissue Sealing Agents Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Hemostatic and Tissue Sealing Agents by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Hemostatic and Tissue Sealing Agents by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Hemostatic and Tissue Sealing Agents Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Hemostatic and Tissue Sealing Agents Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Hemostatic and Tissue Sealing Agents Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Hemostatic and Tissue Sealing Agents Covered in This Study
Table 5. Global Hemostatic and Tissue Sealing Agents Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Hemostatic and Tissue Sealing Agents Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Hemostatic and Tissue Sealing Agents Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Hemostatic and Tissue Sealing Agents Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Hemostatic and Tissue Sealing Agents Manufacturing Sites and Area Served
Table 11. Manufacturers Hemostatic and Tissue Sealing Agents Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Hemostatic and Tissue Sealing Agents by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemostatic and Tissue Sealing Agents as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Hemostatic and Tissue Sealing Agents Sales by Region (2016-2021) & (K Units)
Table 16. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Region (2016-2021)
Table 17. Global Hemostatic and Tissue Sealing Agents Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Hemostatic and Tissue Sealing Agents Sales by Country (2016-2021) & (K Units)
Table 19. North America Hemostatic and Tissue Sealing Agents Sales Market Share by Country (2016-2021)
Table 20. North America Hemostatic and Tissue Sealing Agents Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Hemostatic and Tissue Sealing Agents Revenue Market Share by Country (2016-2021)
Table 22. Europe Hemostatic and Tissue Sealing Agents Sales by Country (2016-2021) & (K Units)
Table 23. Europe Hemostatic and Tissue Sealing Agents Sales Market Share by Country (2016-2021)
Table 24. Europe Hemostatic and Tissue Sealing Agents Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Hemostatic and Tissue Sealing Agents Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Hemostatic and Tissue Sealing Agents Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Hemostatic and Tissue Sealing Agents Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Hemostatic and Tissue Sealing Agents Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Hemostatic and Tissue Sealing Agents Revenue Market Share by Region (2016-2021)
Table 30. Latin America Hemostatic and Tissue Sealing Agents Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Hemostatic and Tissue Sealing Agents Sales Market Share by Country (2016-2021)
Table 32. Latin America Hemostatic and Tissue Sealing Agents Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Hemostatic and Tissue Sealing Agents Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Hemostatic and Tissue Sealing Agents Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Hemostatic and Tissue Sealing Agents Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Hemostatic and Tissue Sealing Agents Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Hemostatic and Tissue Sealing Agents Revenue Market Share by Country (2016-2021)
Table 38. Global Hemostatic and Tissue Sealing Agents Sales (K Units) by Type (2016-2021)
Table 39. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Type (2016-2021)
Table 40. Global Hemostatic and Tissue Sealing Agents Revenue (Million US$) by Type (2016-2021)
Table 41. Global Hemostatic and Tissue Sealing Agents Revenue Share by Type (2016-2021)
Table 42. Global Hemostatic and Tissue Sealing Agents Price (US$/Unit) by Type (2016-2021)
Table 43. Global Hemostatic and Tissue Sealing Agents Sales (K Units) by Application (2016-2021)
Table 44. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Application (2016-2021)
Table 45. Global Hemostatic and Tissue Sealing Agents Revenue (Million US$) by Application (2016-2021)
Table 46. Global Hemostatic and Tissue Sealing Agents Revenue Share by Application (2016-2021)
Table 47. Global Hemostatic and Tissue Sealing Agents Price (US$/Unit) by Application (2016-2021)
Table 48. J&J Corporation Information
Table 49. J&J Description and Business Overview
Table 50. J&J Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. J&J Hemostatic and Tissue Sealing Agents Product
Table 52. J&J Recent Developments/Updates
Table 53. Baxter Corporation Information
Table 54. Baxter Description and Business Overview
Table 55. Baxter Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Baxter Hemostatic and Tissue Sealing Agents Product
Table 57. Baxter Recent Developments/Updates
Table 58. C R Bard Corporation Information
Table 59. C R Bard Description and Business Overview
Table 60. C R Bard Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. C R Bard Hemostatic and Tissue Sealing Agents Product
Table 62. C R Bard Recent Developments/Updates
Table 63. B Braun Corporation Information
Table 64. B Braun Description and Business Overview
Table 65. B Braun Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. B Braun Hemostatic and Tissue Sealing Agents Product
Table 67. B Braun Recent Developments/Updates
Table 68. Integra Life Sciences Corporation Information
Table 69. Integra Life Sciences Description and Business Overview
Table 70. Integra Life Sciences Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Integra Life Sciences Hemostatic and Tissue Sealing Agents Product
Table 72. Integra Life Sciences Recent Developments/Updates
Table 73. Advance Medical Solution Corporation Information
Table 74. Advance Medical Solution Description and Business Overview
Table 75. Advance Medical Solution Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Advance Medical Solution Hemostatic and Tissue Sealing Agents Product
Table 77. Advance Medical Solution Recent Developments/Updates
Table 78. CSL Behring Corporation Information
Table 79. CSL Behring Description and Business Overview
Table 80. CSL Behring Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. CSL Behring Hemostatic and Tissue Sealing Agents Product
Table 82. CSL Behring Recent Developments/Updates
Table 83. CryoLife Corporation Information
Table 84. CryoLife Description and Business Overview
Table 85. CryoLife Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. CryoLife Hemostatic and Tissue Sealing Agents Product
Table 87. CryoLife Recent Developments/Updates
Table 88. Zimmer Biomet Corporation Information
Table 89. Zimmer Biomet Description and Business Overview
Table 90. Zimmer Biomet Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Zimmer Biomet Hemostatic and Tissue Sealing Agents Product
Table 92. Zimmer Biomet Recent Developments/Updates
Table 93. Pfizer Corporation Information
Table 94. Pfizer Description and Business Overview
Table 95. Pfizer Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Pfizer Hemostatic and Tissue Sealing Agents Product
Table 97. Pfizer Recent Developments/Updates
Table 98. Medtronic Corporation Information
Table 99. Medtronic Description and Business Overview
Table 100. Medtronic Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Medtronic Hemostatic and Tissue Sealing Agents Product
Table 102. Medtronic Recent Developments/Updates
Table 103. Smith & Nephew Corporation Information
Table 104. Smith & Nephew Description and Business Overview
Table 105. Smith & Nephew Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Smith & Nephew Hemostatic and Tissue Sealing Agents Product
Table 107. Smith & Nephew Recent Developments/Updates
Table 108. Cohera Medical Corporation Information
Table 109. Cohera Medical Description and Business Overview
Table 110. Cohera Medical Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. Cohera Medical Hemostatic and Tissue Sealing Agents Product
Table 112. Cohera Medical Recent Developments/Updates
Table 113. Shanghai Haohai Biological Technology Co. Ltd. Corporation Information
Table 114. Shanghai Haohai Biological Technology Co. Ltd. Description and Business Overview
Table 115. Shanghai Haohai Biological Technology Co. Ltd. Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. Shanghai Haohai Biological Technology Co. Ltd. Hemostatic and Tissue Sealing Agents Product
Table 117. Shanghai Haohai Biological Technology Co. Ltd. Recent Developments/Updates
Table 118. Shandong Saikesaisi Biotechnology Co., Ltd Corporation Information
Table 119. Shandong Saikesaisi Biotechnology Co., Ltd Description and Business Overview
Table 120. Shandong Saikesaisi Biotechnology Co., Ltd Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. Shandong Saikesaisi Biotechnology Co., Ltd Hemostatic and Tissue Sealing Agents Product
Table 122. Shandong Saikesaisi Biotechnology Co., Ltd Recent Developments/Updates
Table 123. Chang ShaHai Run biological technology Co, LTD Corporation Information
Table 124. Chang ShaHai Run biological technology Co, LTD Description and Business Overview
Table 125. Chang ShaHai Run biological technology Co, LTD Hemostatic and Tissue Sealing Agents Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 126. Chang ShaHai Run biological technology Co, LTD Hemostatic and Tissue Sealing Agents Product
Table 127. Chang ShaHai Run biological technology Co, LTD Recent Developments/Updates
Table 128. Production Base and Market Concentration Rate of Raw Material
Table 129. Key Suppliers of Raw Materials
Table 130. Hemostatic and Tissue Sealing Agents Distributors List
Table 131. Hemostatic and Tissue Sealing Agents Customers List
Table 132. Hemostatic and Tissue Sealing Agents Market Trends
Table 133. Hemostatic and Tissue Sealing Agents Growth Drivers
Table 134. Hemostatic and Tissue Sealing Agents Market Challenges
Table 135. Hemostatic and Tissue Sealing Agents Market Restraints
Table 136. Global Hemostatic and Tissue Sealing Agents Sales Forecast by Type (2022-2027) & (K Units)
Table 137. Global Hemostatic and Tissue Sealing Agents Sales Market Share Forecast by Type (2022-2027)
Table 138. Global Hemostatic and Tissue Sealing Agents Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 139. Global Hemostatic and Tissue Sealing Agents Revenue Market Share Forecast by Type (2022-2027)
Table 140. Global Hemostatic and Tissue Sealing Agents Sales Forecast by Application (2022-2027) & (K Units)
Table 141. Global Hemostatic and Tissue Sealing Agents Sales Market Share Forecast by Application (2022-2027)
Table 142. Global Hemostatic and Tissue Sealing Agents Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 143. Global Hemostatic and Tissue Sealing Agents Revenue Market Share Forecast by Application (2022-2027)
Table 144. Global Hemostatic and Tissue Sealing Agents Sales Forecast by Region (2022-2027) & (K Units)
Table 145. Global Hemostatic and Tissue Sealing Agents Sales Market Share Forecast by Region (2022-2027)
Table 146. Global Hemostatic and Tissue Sealing Agents Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 147. Global Hemostatic and Tissue Sealing Agents Revenue Market Share Forecast by Region (2022-2027)
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Hemostatic and Tissue Sealing Agents
Figure 2. Global Hemostatic and Tissue Sealing Agents Market Share by Type in 2020 & 2027
Figure 3. Hemostatic Product Picture
Figure 4. Sealant Gum Product Picture
Figure 5. Global Hemostatic and Tissue Sealing Agents Market Share by Application in 2020 & 2027
Figure 6. Minimally Invasive Surgery
Figure 7. General Surgery
Figure 8. Other
Figure 9. Global Hemostatic and Tissue Sealing Agents Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Hemostatic and Tissue Sealing Agents Market Size 2016-2027 (US$ Million)
Figure 11. Global Hemostatic and Tissue Sealing Agents Sales 2016-2027 (K Units)
Figure 12. Global Hemostatic and Tissue Sealing Agents Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Hemostatic and Tissue Sealing Agents Sales Share by Manufacturers in 2020
Figure 14. Global Hemostatic and Tissue Sealing Agents Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Hemostatic and Tissue Sealing Agents Players: Market Share by Revenue in 2020
Figure 16. Hemostatic and Tissue Sealing Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Region (2016-2021)
Figure 18. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Region in 2020
Figure 19. Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Region (2016-2021)
Figure 20. Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Region in 2020
Figure 21. U.S. Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. China Taiwan Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Mexico Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Brazil Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Argentina Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Turkey Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Saudi Arabia Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. UAE Hemostatic and Tissue Sealing Agents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Sales Market Share of Hemostatic and Tissue Sealing Agents by Type (2016-2021)
Figure 44. Sales Market Share of Hemostatic and Tissue Sealing Agents by Application (2016-2021)
Figure 45. Sales Market Share of Hemostatic and Tissue Sealing Agents by Application in 2020
Figure 46. Revenue Share of Hemostatic and Tissue Sealing Agents by Application (2016-2021)
Figure 47. Revenue Share of Hemostatic and Tissue Sealing Agents by Application in 2020
Figure 48. Manufacturing Cost Structure of Hemostatic and Tissue Sealing Agents
Figure 49. Manufacturing Process Analysis of Hemostatic and Tissue Sealing Agents
Figure 50. Hemostatic and Tissue Sealing Agents Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’